|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 31/519 | |||
| A61P 19/00 | |||
| A61K 31/506 |
| (11) | Patento numeris | 2790718 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12799204.8 |
| Europos patento paraiškos padavimo data | 2012-12-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-10-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-02-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/075294 |
| Data | 2012-12-12 |
| (87) | Numeris | WO 2013/087725 |
| Data | 2013-06-20 |
| (30) | Numeris | Data | Šalis |
| PCT/IB2011/0032 | 2011-12-12 | WO |
| (72) |
LEGEAI-MALLET, Laurence, FR
MUNNICH, Arnold, FR
BUSCA, Patricia, FR
BARBAULT, Florent, FR
|
| (73) |
Université Paris Descartes,
12, rue de l`Ecole de Médecine, 75006 Paris,
FR
Centre National de la Recherche Scientifique (C.N.R.S.), 3, rue Michel-Ange, 75016 Paris, FR Université Paris Diderot - Paris 7, 5, rue Thomas Mann, 75013 Paris, FR Institut National de la Santé et de la Recherche Médicale (INSERM), 101, rue de Tolbiac, 75013 Paris, FR Assistance Publique Hōpitaux de Paris, 3 Avenue Victoria, 75004 Paris, FR Imagine, 24, Boulevard du Montparnasse, 75015 Paris, FR |
| (54) | ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3 |
| ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3 |